From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis

From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis

Abstract Therapy for relapsing–remitting multiple sclerosis (MS) has advanced dramatically despite incomplete understanding of the cause of the condition. Current treatment involves inducing broad effects on immune cell populations with consequent off‐target side effects, and no treatment can comple...

Full description

Bibliographic Details
Main Authors: Zoe Dyer, David Tscharke, Ian Sutton, Jennifer Massey
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Clinical & Translational Immunology
Subjects:
disease‐modifying therapy
Epstein–Barr virus
multiple sclerosis
translational immunology
Online Access:https://doi.org/10.1002/cti2.1437

Similar Items

Similar Items